Eprosartan

DRUG7 trials

Sponsors

Novartis Pharma AG, Medical University Of Vienna, Regional Hospital Holstebro, University of California, San Francisco, Abbott

Conditions

Covid19Diabetes mellitus Type 2Essential HypertensionHealthyHeart FailureKidney DiseaseSARS-CoV Infection

Phase 1

Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers

CompletedNCT01087749

University of California, San FranciscoKidney Disease

Start: 2010-03-31End: 2012-12-31Updated: 2013-05-30

Phase 2

A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure

CompletedCTIS2023-504678-39-00

Novartis Pharma AGHeart Failure

Start: 2024-03-13End: 2024-11-08Target: 424Updated: 2024-11-08

Phase 3

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

CompletedNCT01631227

AbbottEssential Hypertension

Start: 2012-06-30End: 2013-04-30Updated: 2014-07-25

Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

TerminatedNCT04606563

University of British ColumbiaCovid19, SARS-CoV Infection

Start: 2020-10-09End: 2022-04-22Updated: 2023-02-16

Phase 4

The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.

CompletedNCT00409903

Regional Hospital HolstebroHealthy

Start: 2006-11-30Target: 18Updated: 2007-09-14

The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension

CompletedNCT00438945

Regional Hospital HolstebroEssential Hypertension

Start: 2007-01-31End: 2008-01-31Target: 18Updated: 2008-05-09

NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease; a prospective randomized trial

Not yet recruitingCTIS2024-519051-28-01

Medical University Of ViennaDiabetes mellitus Type 2

Target: 448Updated: 2025-02-17

Related Papers

Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial

Clinical Infectious Diseases2024-07-103 citations